Vanguard Group’s Minerva Surgical, Inc. Common Stock UTRS Stock Holding History

Vanguard Group’s Portfolio UTRS Stock Details UTRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-959	Closed	-$3.15K	–	4590
2023 Q3	$3.15K	Hold	959	–	–	﹤0.01%	4532
2023 Q2	$4.91K	Hold	959	–	–	﹤0.01%	4543
2023 Q1	$4.21K	Hold	959	–	–	﹤0.01%	4553
2022 Q4	$4.29K	Sell	959 -19,799	-95%	-$131K	﹤0.01%	4524
2022 Q3	$330K	Buy	20,758 +1,819	+10%	+$68.9K	﹤0.01%	4328
2022 Q2	$890K	Hold	18,939	–	–	﹤0.01%	4126
2022 Q1	$1.71M	Buy	18,939 +7,446	+65%	+$757K	﹤0.01%	4022
2021 Q4	$1.18M	Buy	+11,493	New	+$1.63M	﹤0.01%	4219

Vanguard Group's UTRS Position: Q4 2023 in Review

Vanguard Group sold out of Minerva Surgical, Inc. Common Stock (UTRS) in Q4 2023, closing a stake of 959 shares — an estimated $3.15K sold.

Vanguard Group first reported a position in UTRS in Q4 2021 and held it in 8 quarters. The position peaked at $1.71M in Q1 2022. 0 funds tracked by Wall St. Rank hold UTRS as of Q4 2023.

Vanguard Group reported no remaining Minerva Surgical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Vanguard Group sold 959 Minerva Surgical, Inc. Common Stock shares in Q4 2023, an estimated $3.15K.
Vanguard Group first reported a position in Minerva Surgical, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
Vanguard Group's Minerva Surgical, Inc. Common Stock position peaked at $1.71M in Q1 2022.
0 funds tracked by Wall St. Rank held Minerva Surgical, Inc. Common Stock as of Q4 2023.

Based on Vanguard Group's 13F filing for Q4 2023, filed 14 Feb 2024.